Skip to main content
. 2021 May 23;13(11):2553. doi: 10.3390/cancers13112553

Figure 5.

Figure 5

Kaplan–Meier figures with survival after a loco-regional or distant recurrence (LRR/DR) separated for HPV and p16 status. No significant differences were observed in survival between patients with TSCC/BOTSCC after recurrent disease independent of HPV and p16 status. (HPV+p16+ vs. HPV−p16− (log rank test): p = 0.17).